Sanofi SA has entered into a collaboration with the Michael J. Fox Foundation to conduct a clinical trial to assess the safety and tolerability of a Sanofi phosphodiesterase type 4 inhibitor for patients with Parkinson’s disease. ---Subscribe to MedNous to access this article--- Company News Finance, Grants, Deals
